JACOBS JOEY A 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed May 10, 2019
Insider Transaction Report
Form 4
JACOBS JOEY A
Director
Transactions
- Purchase
Common Stock
2019-04-26$5.92/sh+236$1,397→ 78,110 total - Purchase
Common Stock
2019-04-29$5.81/sh+343$1,993→ 78,453 total - Purchase
Common Stock
2019-04-30$5.74/sh+98$563→ 78,551 total - Purchase
Common Stock
2019-05-01$5.51/sh+441$2,430→ 78,992 total - Purchase
Common Stock
2019-05-02$5.38/sh+748$4,024→ 79,740 total - Purchase
Common Stock
2019-05-06$6.16/sh+686$4,226→ 80,426 total - Purchase
Common Stock
2019-05-07$5.83/sh+361$2,105→ 80,787 total - Purchase
Common Stock
2019-05-08$6.26/sh+933$5,841→ 81,720 total
Footnotes (1)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019.